Extended Data Fig. 1: Integration site analysis (ISA) for the patients with SCD. | Nature Medicine

Extended Data Fig. 1: Integration site analysis (ISA) for the patients with SCD.

From: Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

Extended Data Fig. 1

ISA kinetics for each of the 3 SCD patients, showing relative abundance of vector-marked cell clones. Each of the most represented unique integration sites (UISs) is indicated by a different color, with white showing the cumulative proportion of all other UISs and their names as a side table. The total number of UISs is indicated at the top of each column. SCD-2 M54 provided post datacut.

Back to article page